- Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?
-
Albert C, Haase M, Albert A, Zapf A, Braun-Dullaeus RC, Haase-Fielitz A
- KMID: 2512729
- Ann Lab Med.
- 2021 Jan;41(1):1-15.
- doi: 10.3343/alm.2021.41.1.1
Acute kidney injury (AKI) is a common and serious complication in hospitalized patients, which continues to pose a clinical challenge for treating physicians. The most recent Kidney Disease Improving Global... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Value of Plasma NGAL:Hepcidin-25 for Major Adverse Kidney Events After Cardiac Surgery with Cardiopulmonary Bypass: A Pilot Study
-
Albert C, Haase M, Albert A, Ernst M, Kropf S, Bellomo R, Westphal S, Braun-Dullaeus RC, Haase-Fielitz A, Elitok S
- KMID: 2512714
- Ann Lab Med.
- 2021 Jul;41(4):357-365.
- doi: 10.3343/alm.2021.41.4.357
Background: Neutrophil gelatinase-associated lipocalin (NGAL) and hepcidin-25 are involved in catalytic iron-related kidney injury after cardiac surgery with cardiopulmonary bypass. We explored the predictive value of plasma NGAL, plasma hepcidin-25,... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary Biomarkers may Complement the Cleveland Score for Prediction of Adverse Kidney Events After Cardiac Surgery: A Pilot Study
-
Albert C, Haase M, Albert A, Kropf S, Bellomo R, Westphal S, Westerman , Braun-Dullaeus RC, Haase-Fielitz A
- KMID: 2460910
- Ann Lab Med.
- 2020 Mar;40(2):131-141.
- doi: 10.3343/alm.2020.40.2.131
BACKGROUND: The ability of urinary biomarkers to complement established clinical risk prediction models for postoperative adverse kidney events is unclear. We assessed the effect of urinary biomarkers linked to suspected... -
- CITED
-
- Close
- SHARE
-
- Close
